Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
Nielsen W, Strand V, Simon LS, Parodis I, Kim AHJ, Desai M, Enman Y, Wallace D, Chaichian Y, Navarra S, Aranow C, MacKay M, Trotter K, Tayer-Shifman OE, Duarte-Garcia A, Shan Tam L, Ugarte-Gil MF, PonsEstel GJ, Reynolds JA, Nikpour M, Hoi A, Romero-Diaz J, Papachristos D, Aggarwal A, Mok CC, Fujio K, Ramsey-Goldman R, Howe A, Kia BN, Bonilla D, Thumboo J, Mosca M, Aringer M, Johnson SR, Drucker AM, Morand E, Bruce I, Touma Z; OMERACT SLE Working Group. Nielsen W, et al. Among authors: aringer m. Semin Arthritis Rheum. 2024 Apr;65:152380. doi: 10.1016/j.semarthrit.2024.152380. Epub 2024 Jan 14. Semin Arthritis Rheum. 2024. PMID: 38281467
[Assessment tools for systemic lupus erythematosus].
Aringer M, Leuchten N. Aringer M, et al. Z Rheumatol. 2023 Jun;82(5):361-367. doi: 10.1007/s00393-023-01359-w. Epub 2023 May 15. Z Rheumatol. 2023. PMID: 37188996 Review. German.
[Baricitinib for systemic lupus erythematosus].
Aringer M, Nitschmann S. Aringer M, et al. Inn Med (Heidelb). 2023 Aug;64(8):815-818. doi: 10.1007/s00108-023-01547-5. Epub 2023 Jul 11. Inn Med (Heidelb). 2023. PMID: 37432406 German. No abstract available.
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
Allanore Y, Khanna D, Smith V, Aringer M, Hoffmann-Vold AM, Kuwana M, Merkel PA, Stock C, Sambevski S, Denton CP; SENSCIS Trial Investigators. Allanore Y, et al. Among authors: aringer m. Rheumatology (Oxford). 2024 Mar 1;63(3):639-647. doi: 10.1093/rheumatology/kead280. Rheumatology (Oxford). 2024. PMID: 37294870 Free PMC article. Clinical Trial.
302 results